On Thursday, BMO Capital Markets initiated coverage on Corebridge Financial, trading on the New York Stock Exchange under the ticker (NYSE:CRBG), with an Outperform rating and a price target of $ ...

BMO Capital Markets downgraded Novo Nordisk (NYSE:NVO) to “Market Perform” from “Outperform” and cut its price target to $64, saying the Danish drugmaker’s early lead in the obesity drug market is ...

BMO Capital on Wednesday cut its year-end 2025 S&P 500 target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent selloff. In a note to clients, chief investment strategis ...

The mounting uncertainty has now prompted BMO Capital Markets to lower its year-end target ... roughly 15% from current levels to hit BMO's new target of 6,100. Looking across sectors, BMO also ...

AvalonBay Communities (NYSE:AVB – Get Free Report) was downgraded by analysts at BMO Capital Markets from an “outperform” ...

On Wednesday, BMO Capital Markets maintained its Market Perform ... which took place in New York on Tuesday, March 4, 2025. The event highlighted the company’s solid business model and its ...

NEW YORK, April 9 (Reuters) - BMO Capital on Wednesday cut its year-end 2025 S&P 500 (.SPX), opens new tab target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent ...